Home Healthcare Pharmaceuticals Thrombin Market

Thrombin Market Size, Share & Trends Analysis Report By Product Type (Bovine Thrombin, Human Thrombin, Recombinant Thrombin), By Dosage Form (Powder Form, Solution Form), By Application (Surgical Wounds, Trauma Cases, Cardiovascular Surgery, Orthopedic Surgery, Neurosurgery, Others), By End-User (Hospitals, Clinics, Ambulatory Surgical Centers (ASCs), Others) and By Country (U.S., Canada) Forecasts, 2026-2034

Last Updated: July 09, 2026 | Author: Mitiksha Koul | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Thrombin Market, By Product Type 2022-2034 (USD MILLION/ Units)
    1. Bovine Thrombin
    2. Human Thrombin
    3. Recombinant Thrombin
  2. Thrombin Market, By Dosage Form 2022-2034 (USD MILLION/ Units)
    1. Powder Form
    2. Solution Form
  3. Thrombin Market, By Application 2022-2034 (USD MILLION/ Units)
    1. Surgical Wounds
    2. Trauma Cases
    3. Cardiovascular Surgery
    4. Orthopedic Surgery
    5. Neurosurgery
    6. Others
  4. Thrombin Market, By End-User 2022-2034 (USD MILLION/ Units)
    1. Hospitals
    2. Clinics
    3. Ambulatory Surgical Centers (ASCs)
    4. Others
  5. Regional Thrombin Market
    1. North America
      1. North America Thrombin Market By Product Type 2022-2034 (USD MILLION/ Units)
        1. Bovine Thrombin
        2. Human Thrombin
        3. Recombinant Thrombin
      2. North America Thrombin Market By Dosage Form 2022-2034 (USD MILLION/ Units)
        1. Powder Form
        2. Solution Form
      3. North America Thrombin Market By Application 2022-2034 (USD MILLION/ Units)
        1. Surgical Wounds
        2. Trauma Cases
        3. Cardiovascular Surgery
        4. Orthopedic Surgery
        5. Neurosurgery
        6. Others
      4. North America Thrombin Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Ambulatory Surgical Centers (ASCs)
        4. Others
      5. U.S.
        1. Bovine Thrombin
        2. Human Thrombin
        3. Recombinant Thrombin
        4. Powder Form
        5. Solution Form
        6. Surgical Wounds
        7. Trauma Cases
        8. Cardiovascular Surgery
        9. Orthopedic Surgery
        10. Neurosurgery
        11. Others
        12. Hospitals
        13. Clinics
        14. Ambulatory Surgical Centers (ASCs)
        15. Others
      6. Canada
        1. Bovine Thrombin
        2. Human Thrombin
        3. Recombinant Thrombin
        4. Powder Form
        5. Solution Form
        6. Surgical Wounds
        7. Trauma Cases
        8. Cardiovascular Surgery
        9. Orthopedic Surgery
        10. Neurosurgery
        11. Others
        12. Hospitals
        13. Clinics
        14. Ambulatory Surgical Centers (ASCs)
        15. Others
    2. Europe
      1. Europe Thrombin Market By Product Type 2022-2034 (USD MILLION/ Units)
        1. Bovine Thrombin
        2. Human Thrombin
        3. Recombinant Thrombin
      2. Europe Thrombin Market By Dosage Form 2022-2034 (USD MILLION/ Units)
        1. Powder Form
        2. Solution Form
      3. Europe Thrombin Market By Application 2022-2034 (USD MILLION/ Units)
        1. Surgical Wounds
        2. Trauma Cases
        3. Cardiovascular Surgery
        4. Orthopedic Surgery
        5. Neurosurgery
        6. Others
      4. Europe Thrombin Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Ambulatory Surgical Centers (ASCs)
        4. Others
      5. U.K.
        1. Bovine Thrombin
        2. Human Thrombin
        3. Recombinant Thrombin
        4. Powder Form
        5. Solution Form
        6. Surgical Wounds
        7. Trauma Cases
        8. Cardiovascular Surgery
        9. Orthopedic Surgery
        10. Neurosurgery
        11. Others
        12. Hospitals
        13. Clinics
        14. Ambulatory Surgical Centers (ASCs)
        15. Others
      6. Germany
        1. Bovine Thrombin
        2. Human Thrombin
        3. Recombinant Thrombin
        4. Powder Form
        5. Solution Form
        6. Surgical Wounds
        7. Trauma Cases
        8. Cardiovascular Surgery
        9. Orthopedic Surgery
        10. Neurosurgery
        11. Others
        12. Hospitals
        13. Clinics
        14. Ambulatory Surgical Centers (ASCs)
        15. Others
      7. France
        1. Bovine Thrombin
        2. Human Thrombin
        3. Recombinant Thrombin
        4. Powder Form
        5. Solution Form
        6. Surgical Wounds
        7. Trauma Cases
        8. Cardiovascular Surgery
        9. Orthopedic Surgery
        10. Neurosurgery
        11. Others
        12. Hospitals
        13. Clinics
        14. Ambulatory Surgical Centers (ASCs)
        15. Others
      8. Spain
        1. Bovine Thrombin
        2. Human Thrombin
        3. Recombinant Thrombin
        4. Powder Form
        5. Solution Form
        6. Surgical Wounds
        7. Trauma Cases
        8. Cardiovascular Surgery
        9. Orthopedic Surgery
        10. Neurosurgery
        11. Others
        12. Hospitals
        13. Clinics
        14. Ambulatory Surgical Centers (ASCs)
        15. Others
      9. Italy
        1. Bovine Thrombin
        2. Human Thrombin
        3. Recombinant Thrombin
        4. Powder Form
        5. Solution Form
        6. Surgical Wounds
        7. Trauma Cases
        8. Cardiovascular Surgery
        9. Orthopedic Surgery
        10. Neurosurgery
        11. Others
        12. Hospitals
        13. Clinics
        14. Ambulatory Surgical Centers (ASCs)
        15. Others
      10. Russia
        1. Bovine Thrombin
        2. Human Thrombin
        3. Recombinant Thrombin
        4. Powder Form
        5. Solution Form
        6. Surgical Wounds
        7. Trauma Cases
        8. Cardiovascular Surgery
        9. Orthopedic Surgery
        10. Neurosurgery
        11. Others
        12. Hospitals
        13. Clinics
        14. Ambulatory Surgical Centers (ASCs)
        15. Others
      11. Nordic
        1. Bovine Thrombin
        2. Human Thrombin
        3. Recombinant Thrombin
        4. Powder Form
        5. Solution Form
        6. Surgical Wounds
        7. Trauma Cases
        8. Cardiovascular Surgery
        9. Orthopedic Surgery
        10. Neurosurgery
        11. Others
        12. Hospitals
        13. Clinics
        14. Ambulatory Surgical Centers (ASCs)
        15. Others
      12. Benelux
        1. Bovine Thrombin
        2. Human Thrombin
        3. Recombinant Thrombin
        4. Powder Form
        5. Solution Form
        6. Surgical Wounds
        7. Trauma Cases
        8. Cardiovascular Surgery
        9. Orthopedic Surgery
        10. Neurosurgery
        11. Others
        12. Hospitals
        13. Clinics
        14. Ambulatory Surgical Centers (ASCs)
        15. Others
      13. Rest of Europe
        1. Bovine Thrombin
        2. Human Thrombin
        3. Recombinant Thrombin
        4. Powder Form
        5. Solution Form
        6. Surgical Wounds
        7. Trauma Cases
        8. Cardiovascular Surgery
        9. Orthopedic Surgery
        10. Neurosurgery
        11. Others
        12. Hospitals
        13. Clinics
        14. Ambulatory Surgical Centers (ASCs)
        15. Others
    3. APAC
      1. APAC Thrombin Market By Product Type 2022-2034 (USD MILLION/ Units)
        1. Bovine Thrombin
        2. Human Thrombin
        3. Recombinant Thrombin
      2. APAC Thrombin Market By Dosage Form 2022-2034 (USD MILLION/ Units)
        1. Powder Form
        2. Solution Form
      3. APAC Thrombin Market By Application 2022-2034 (USD MILLION/ Units)
        1. Surgical Wounds
        2. Trauma Cases
        3. Cardiovascular Surgery
        4. Orthopedic Surgery
        5. Neurosurgery
        6. Others
      4. APAC Thrombin Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Ambulatory Surgical Centers (ASCs)
        4. Others
      5. China
        1. Bovine Thrombin
        2. Human Thrombin
        3. Recombinant Thrombin
        4. Powder Form
        5. Solution Form
        6. Surgical Wounds
        7. Trauma Cases
        8. Cardiovascular Surgery
        9. Orthopedic Surgery
        10. Neurosurgery
        11. Others
        12. Hospitals
        13. Clinics
        14. Ambulatory Surgical Centers (ASCs)
        15. Others
      6. Korea
        1. Bovine Thrombin
        2. Human Thrombin
        3. Recombinant Thrombin
        4. Powder Form
        5. Solution Form
        6. Surgical Wounds
        7. Trauma Cases
        8. Cardiovascular Surgery
        9. Orthopedic Surgery
        10. Neurosurgery
        11. Others
        12. Hospitals
        13. Clinics
        14. Ambulatory Surgical Centers (ASCs)
        15. Others
      7. Japan
        1. Bovine Thrombin
        2. Human Thrombin
        3. Recombinant Thrombin
        4. Powder Form
        5. Solution Form
        6. Surgical Wounds
        7. Trauma Cases
        8. Cardiovascular Surgery
        9. Orthopedic Surgery
        10. Neurosurgery
        11. Others
        12. Hospitals
        13. Clinics
        14. Ambulatory Surgical Centers (ASCs)
        15. Others
      8. India
        1. Bovine Thrombin
        2. Human Thrombin
        3. Recombinant Thrombin
        4. Powder Form
        5. Solution Form
        6. Surgical Wounds
        7. Trauma Cases
        8. Cardiovascular Surgery
        9. Orthopedic Surgery
        10. Neurosurgery
        11. Others
        12. Hospitals
        13. Clinics
        14. Ambulatory Surgical Centers (ASCs)
        15. Others
      9. Australia
        1. Bovine Thrombin
        2. Human Thrombin
        3. Recombinant Thrombin
        4. Powder Form
        5. Solution Form
        6. Surgical Wounds
        7. Trauma Cases
        8. Cardiovascular Surgery
        9. Orthopedic Surgery
        10. Neurosurgery
        11. Others
        12. Hospitals
        13. Clinics
        14. Ambulatory Surgical Centers (ASCs)
        15. Others
      10. Taiwan
        1. Bovine Thrombin
        2. Human Thrombin
        3. Recombinant Thrombin
        4. Powder Form
        5. Solution Form
        6. Surgical Wounds
        7. Trauma Cases
        8. Cardiovascular Surgery
        9. Orthopedic Surgery
        10. Neurosurgery
        11. Others
        12. Hospitals
        13. Clinics
        14. Ambulatory Surgical Centers (ASCs)
        15. Others
      11. South East Asia
        1. Bovine Thrombin
        2. Human Thrombin
        3. Recombinant Thrombin
        4. Powder Form
        5. Solution Form
        6. Surgical Wounds
        7. Trauma Cases
        8. Cardiovascular Surgery
        9. Orthopedic Surgery
        10. Neurosurgery
        11. Others
        12. Hospitals
        13. Clinics
        14. Ambulatory Surgical Centers (ASCs)
        15. Others
      12. Rest of Asia-Pacific
        1. Bovine Thrombin
        2. Human Thrombin
        3. Recombinant Thrombin
        4. Powder Form
        5. Solution Form
        6. Surgical Wounds
        7. Trauma Cases
        8. Cardiovascular Surgery
        9. Orthopedic Surgery
        10. Neurosurgery
        11. Others
        12. Hospitals
        13. Clinics
        14. Ambulatory Surgical Centers (ASCs)
        15. Others
    4. Middle East and Africa
      1. Middle East and Africa Thrombin Market By Product Type 2022-2034 (USD MILLION/ Units)
        1. Bovine Thrombin
        2. Human Thrombin
        3. Recombinant Thrombin
      2. Middle East and Africa Thrombin Market By Dosage Form 2022-2034 (USD MILLION/ Units)
        1. Powder Form
        2. Solution Form
      3. Middle East and Africa Thrombin Market By Application 2022-2034 (USD MILLION/ Units)
        1. Surgical Wounds
        2. Trauma Cases
        3. Cardiovascular Surgery
        4. Orthopedic Surgery
        5. Neurosurgery
        6. Others
      4. Middle East and Africa Thrombin Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Ambulatory Surgical Centers (ASCs)
        4. Others
      5. UAE
        1. Bovine Thrombin
        2. Human Thrombin
        3. Recombinant Thrombin
        4. Powder Form
        5. Solution Form
        6. Surgical Wounds
        7. Trauma Cases
        8. Cardiovascular Surgery
        9. Orthopedic Surgery
        10. Neurosurgery
        11. Others
        12. Hospitals
        13. Clinics
        14. Ambulatory Surgical Centers (ASCs)
        15. Others
      6. Turkey
        1. Bovine Thrombin
        2. Human Thrombin
        3. Recombinant Thrombin
        4. Powder Form
        5. Solution Form
        6. Surgical Wounds
        7. Trauma Cases
        8. Cardiovascular Surgery
        9. Orthopedic Surgery
        10. Neurosurgery
        11. Others
        12. Hospitals
        13. Clinics
        14. Ambulatory Surgical Centers (ASCs)
        15. Others
      7. Saudi Arabia
        1. Bovine Thrombin
        2. Human Thrombin
        3. Recombinant Thrombin
        4. Powder Form
        5. Solution Form
        6. Surgical Wounds
        7. Trauma Cases
        8. Cardiovascular Surgery
        9. Orthopedic Surgery
        10. Neurosurgery
        11. Others
        12. Hospitals
        13. Clinics
        14. Ambulatory Surgical Centers (ASCs)
        15. Others
      8. South Africa
        1. Bovine Thrombin
        2. Human Thrombin
        3. Recombinant Thrombin
        4. Powder Form
        5. Solution Form
        6. Surgical Wounds
        7. Trauma Cases
        8. Cardiovascular Surgery
        9. Orthopedic Surgery
        10. Neurosurgery
        11. Others
        12. Hospitals
        13. Clinics
        14. Ambulatory Surgical Centers (ASCs)
        15. Others
      9. Egypt
        1. Bovine Thrombin
        2. Human Thrombin
        3. Recombinant Thrombin
        4. Powder Form
        5. Solution Form
        6. Surgical Wounds
        7. Trauma Cases
        8. Cardiovascular Surgery
        9. Orthopedic Surgery
        10. Neurosurgery
        11. Others
        12. Hospitals
        13. Clinics
        14. Ambulatory Surgical Centers (ASCs)
        15. Others
      10. Nigeria
        1. Bovine Thrombin
        2. Human Thrombin
        3. Recombinant Thrombin
        4. Powder Form
        5. Solution Form
        6. Surgical Wounds
        7. Trauma Cases
        8. Cardiovascular Surgery
        9. Orthopedic Surgery
        10. Neurosurgery
        11. Others
        12. Hospitals
        13. Clinics
        14. Ambulatory Surgical Centers (ASCs)
        15. Others
      11. Rest of MEA
        1. Bovine Thrombin
        2. Human Thrombin
        3. Recombinant Thrombin
        4. Powder Form
        5. Solution Form
        6. Surgical Wounds
        7. Trauma Cases
        8. Cardiovascular Surgery
        9. Orthopedic Surgery
        10. Neurosurgery
        11. Others
        12. Hospitals
        13. Clinics
        14. Ambulatory Surgical Centers (ASCs)
        15. Others
    5. LATAM
      1. LATAM Thrombin Market By Product Type 2022-2034 (USD MILLION/ Units)
        1. Bovine Thrombin
        2. Human Thrombin
        3. Recombinant Thrombin
      2. LATAM Thrombin Market By Dosage Form 2022-2034 (USD MILLION/ Units)
        1. Powder Form
        2. Solution Form
      3. LATAM Thrombin Market By Application 2022-2034 (USD MILLION/ Units)
        1. Surgical Wounds
        2. Trauma Cases
        3. Cardiovascular Surgery
        4. Orthopedic Surgery
        5. Neurosurgery
        6. Others
      4. LATAM Thrombin Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Ambulatory Surgical Centers (ASCs)
        4. Others
      5. Brazil
        1. Bovine Thrombin
        2. Human Thrombin
        3. Recombinant Thrombin
        4. Powder Form
        5. Solution Form
        6. Surgical Wounds
        7. Trauma Cases
        8. Cardiovascular Surgery
        9. Orthopedic Surgery
        10. Neurosurgery
        11. Others
        12. Hospitals
        13. Clinics
        14. Ambulatory Surgical Centers (ASCs)
        15. Others
      6. Mexico
        1. Bovine Thrombin
        2. Human Thrombin
        3. Recombinant Thrombin
        4. Powder Form
        5. Solution Form
        6. Surgical Wounds
        7. Trauma Cases
        8. Cardiovascular Surgery
        9. Orthopedic Surgery
        10. Neurosurgery
        11. Others
        12. Hospitals
        13. Clinics
        14. Ambulatory Surgical Centers (ASCs)
        15. Others
      7. Argentina
        1. Bovine Thrombin
        2. Human Thrombin
        3. Recombinant Thrombin
        4. Powder Form
        5. Solution Form
        6. Surgical Wounds
        7. Trauma Cases
        8. Cardiovascular Surgery
        9. Orthopedic Surgery
        10. Neurosurgery
        11. Others
        12. Hospitals
        13. Clinics
        14. Ambulatory Surgical Centers (ASCs)
        15. Others
      8. Chile
        1. Bovine Thrombin
        2. Human Thrombin
        3. Recombinant Thrombin
        4. Powder Form
        5. Solution Form
        6. Surgical Wounds
        7. Trauma Cases
        8. Cardiovascular Surgery
        9. Orthopedic Surgery
        10. Neurosurgery
        11. Others
        12. Hospitals
        13. Clinics
        14. Ambulatory Surgical Centers (ASCs)
        15. Others
      9. Colombia
        1. Bovine Thrombin
        2. Human Thrombin
        3. Recombinant Thrombin
        4. Powder Form
        5. Solution Form
        6. Surgical Wounds
        7. Trauma Cases
        8. Cardiovascular Surgery
        9. Orthopedic Surgery
        10. Neurosurgery
        11. Others
        12. Hospitals
        13. Clinics
        14. Ambulatory Surgical Centers (ASCs)
        15. Others
      10. Rest of LATAM
        1. Bovine Thrombin
        2. Human Thrombin
        3. Recombinant Thrombin
        4. Powder Form
        5. Solution Form
        6. Surgical Wounds
        7. Trauma Cases
        8. Cardiovascular Surgery
        9. Orthopedic Surgery
        10. Neurosurgery
        11. Others
        12. Hospitals
        13. Clinics
        14. Ambulatory Surgical Centers (ASCs)
        15. Others
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.